Cargando…

The influenza vaccines roadmap – A better future through improved influenza vaccines

Detalles Bibliográficos
Autores principales:	Hart, Peter, Farrar, Jeremy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8499092/ https://www.ncbi.nlm.nih.gov/pubmed/34635377 http://dx.doi.org/10.1016/j.vaccine.2021.09.071

Ejemplares similares

Vaccines for Improved Cellular Immunity to Influenza
por: Pawelec, Graham, et al.
Publicado: (2018)

How to improve influenza vaccine coverage of healthcare personnel
por: Weber, David J., et al.
Publicado: (2016)

Successes and Failures of the Live-attenuated Influenza Vaccine: Can We Do Better?
por: Matrajt, Laura, et al.
Publicado: (2020)

Making Better Influenza Virus Vaccines?
por: Palese, Peter
Publicado: (2006)

Technology transfer programme for influenza vaccines – Lessons from the past to inform the future
por: Chadwick, Christopher, et al.
Publicado: (2022)

Universal influenza vaccines: Shifting to better vaccines
por: Berlanda Scorza, Francesco, et al.
Publicado: (2016)

Seasonal influenza vaccination during a pandemic
por: Richmond, Heather, et al.
Publicado: (2020)

Pandemic Influenza Vaccines: What did We Learn from the 2009 Pandemic and are We Better Prepared Now?
por: Rockman, Steven, et al.
Publicado: (2020)

Virus-like particle (VLP)-based vaccines for pandemic influenza: Performance of a VLP vaccine during the 2009 influenza pandemic
por: López-Macías, Constantino
Publicado: (2012)

Better influenza vaccines: an industry perspective
por: Chen, Juine-Ruey, et al.
Publicado: (2020)

Mechanistic insights into influenza vaccine-associated narcolepsy
por: Ahmed, S. Sohail, et al.
Publicado: (2016)

Making evidence-based selections of influenza vaccines
por: Childress, Billy-Clyde, et al.
Publicado: (2014)

Impact of Pre-Existing Immunity to Influenza on Live-Attenuated Influenza Vaccine (LAIV) Immunogenicity
por: Roy, Sreeja, et al.
Publicado: (2020)

Roadmap for Sex-Responsive Influenza and COVID-19 Vaccine Research in Older Adults
por: Shapiro, Janna R., et al.
Publicado: (2022)

Seasonal vaccines – Critical path to pandemic influenza response
por: Zhang, Wenqing, et al.
Publicado: (2017)

Experience and challenges on influenza and pertussis vaccination in pregnant women
por: Madhi, Shabir A., et al.
Publicado: (2018)

A review of epidemic preparedness for influenza through local vaccine production: national security for Thailand
por: Pitisuttithum, Punnee, et al.
Publicado: (2019)

mRNA, the beginning of a new influenza vaccine game
por: Pecetta, Simone, et al.
Publicado: (2022)

Influenza immunization among Chinese seniors: Urgent calling for improving vaccination coverage, education, and research
por: Li, Xin, et al.
Publicado: (2020)

Incorporating Research and Evaluation into Pandemic Influenza Vaccination Preparedness and Response
por: Shimabukuro, Tom T., et al.
Publicado: (2014)

Costs and benefits of influenza vaccination: more evidence, same challenges
por: Ciancio, Bruno Christian, et al.
Publicado: (2014)

Functional Genetics in the Post-genomics Era: Building a Better Roadmap in Drosophila
por: Kulathinal, Rob J.
Publicado: (2013)

Functional Genetics in the Post-Genomics Era: Building a Better Roadmap in Drosophila
por: Kulathinal, Rob J.
Publicado: (2013)

Beyond Influenza Vaccination: Expanding Infrastructure for Hospital-based Pediatric COVID-19 Vaccine Delivery
por: Hofstetter, Annika M., et al.
Publicado: (2022)

Is It Possible? A Different Approach to Creating a Universal Influenza Vaccine
por: Schultz-Cherry, Stacey
Publicado: (2015)

An overview of the regulation of influenza vaccines in the United States
por: Weir, Jerry P., et al.
Publicado: (2016)

Modeling Influenza Virus Infection: A Roadmap for Influenza Research
por: Boianelli, Alessandro, et al.
Publicado: (2015)

Childhood vaccination against seasonal influenza – is there a risk of undesirable outcomes?
por: Baguelin, Marc, et al.
Publicado: (2020)

Influenza Neuraminidase: A Neglected Protein and Its Potential for a Better Influenza Vaccine
por: Giurgea, Luca T., et al.
Publicado: (2020)

A review of the changes to the licensing of influenza vaccines in Europe
por: Wijnans, Leonoor, et al.
Publicado: (2015)

Expanding global and national influenza vaccine systems to match the COVID-19 pandemic response
por: Ruscio, Bruce A., et al.
Publicado: (2020)

Four New Vaccines for Routine Immunization in India: What About Hemophilus Influenza B and Pneumococcal Vaccine?
por: Paul, Sourabh, et al.
Publicado: (2015)

Development of vaccines for influenza disease: Opportunity costs of the COVID-19 pandemic
por: Wiemken, Timothy L., et al.
Publicado: (2021)

Influenza vaccines and vaccinations in Poland – past, present and future
por: Brydak, Lidia B., et al.
Publicado: (2012)

Intervention programs to increase influenza vaccination in Israel: which is the preferred one?
por: Grotto, Itamar, et al.
Publicado: (2014)

Standardisation of inactivated influenza vaccines—Learning from history
por: Wood, John M., et al.
Publicado: (2018)

Mass vaccination campaign during the 2016 influenza outbreak in Panama: Challenges and implications for COVID-19 vaccination efforts
por: Castro, Franz, et al.
Publicado: (2022)

Relative Effectiveness of Adjuvanted Trivalent Inactivated Influenza Vaccine Versus Egg-derived Quadrivalent Inactivated Influenza Vaccines and High-dose Trivalent Influenza Vaccine in Preventing Influenza-related Medical Encounters in US Adults ≥ 65 Years During the 2017–2018 and 2018–2019 Influenza Seasons
por: Boikos, Constantina, et al.
Publicado: (2021)

The importance of seasonal influenza vaccination for people with disabilities during the COVID-19 pandemic
por: Peacock, Georgina, et al.
Publicado: (2021)

Estimating Influenza Vaccine Efficacy From Challenge and Community-based Study Data
por: Basta, Nicole E., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_sc3tgp14sdtfuotrj5f7j3p6oh